ClinicalTrials.gg
Sign In

Carcinoma, Islet Cell clinical trials

The registry lists 38 studies for Carcinoma, Islet Cell across more than 10 countries. 1 are recruiting or about to start. 5 of them are mainly about Carcinoma, Islet Cell (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-29. Counting its 4 narrower conditions too, such as Somatostatinoma: 71 studies, 2 open.

Get an email when these change. Save the Carcinoma, Islet Cell studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
25
Terminated
9
Withdrawn
3
Recruiting
1

Phase

Phase 2
25
Phase 1
10
Phase 3
3

Where

United States
33
Canada
3
United Kingdom
2
France
2
Australia
2
Germany
2

Who runs them

National Cancer Institute (NCI) (6) · Novartis Pharmaceuticals (2) · University of Southern California (2) · Mayo Clinic (2) · Yale University (2) · ECOG-ACRIN Cancer Research Group (2) · Memorial Sloan Kettering Cancer Center (2) · Eastern Cooperative Oncology Group (2)

What is being tested here

Drugs under test in Carcinoma, Islet Cell studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Everolimus005
Temozolomide003
Vatalanib002
Capecitabine002
Bevacizumab012
Temsirolimus002
Melphalan002
Octreotide002
Motesanib diphosphate001
Regorafenib001

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 9 · mTOR inhibitors 7 · Alkylating agents 5 · Antimetabolites 4 · Angiogenesis inhibitors 3

Coming up

0phase 3 studies under way
1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Who these studies take

Of the 1 Carcinoma, Islet Cell studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 1
AgeWomenMen
100 (0%)0 (0%)
181 (100%)1 (100%)
301 (100%)1 (100%)
401 (100%)1 (100%)
501 (100%)1 (100%)
651 (100%)1 (100%)
751 (100%)1 (100%)
851 (100%)1 (100%)

Across all 38 studies, recruiting or not: 3% stop at 75 or younger and 3% at 65; 11% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 38 of 38. search them.